NASDAQ:ALGN - Align Technology Stock Price, Price Target & More

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) announced its earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.17 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.98 by $0.19. The medical equipment provider had revenue of $436.92 million for the quarter, compared to analysts' expectations of $408.27 million. Align Technology had a return on equity of 30.36% and a net margin of 16.12%. The firm's revenue was up 40.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Align Technology.

Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.

15 Wall Street analysts have issued 1-year target prices for Align Technology's shares. Their predictions range from $210.00 to $420.00. On average, they expect Align Technology's share price to reach $313.3333 in the next year. View Analyst Ratings for Align Technology.

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), CONSORT Med PLC/S (CSRMY), Invacare (IVC), Sientra (SIEN) and RTI Surgical (RTIX).

News articles about ALGN stock have trended somewhat negative on Monday, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Align Technology earned a daily sentiment score of -0.07 on Accern's scale. They also gave news articles about the medical equipment provider an impact score of 46.88 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Align Technology's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.32%), Polen Capital Management LLC (3.33%), Disciplined Growth Investors Inc. MN (1.20%), Old Mutual Global Investors UK Ltd. (0.90%), Federated Investors Inc. PA (0.72%) and Victory Capital Management Inc. (0.61%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Fiera Capital Corp, Victory Capital Management Inc., Ownership Capital B.V., Smith Asset Management Group LP, Frontier Capital Management Co. LLC, BlackRock Inc. and Sei Investments Co.. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.

ALGN stock was bought by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, TCW Group Inc., Lord Abbett & CO. LLC, Massachusetts Financial Services Co. MA, Prudential Financial Inc., Carillon Tower Advisers Inc., Polen Capital Management LLC and Motley Fool Asset Management LLC. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $344.33.

Align Technology has a market capitalization of $28.31 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.

Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]